AIM ImmunoTech, Inc. (AIM)

1.28 -0.02 (-1.54%) USD  |  NYAM  |  Dec 24, 12:59
1.32 +0.04 (+3.12%) After-Hours: 13:59
More

AIM ImmunoTech SG&A Expense (TTM): 10.06M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. 172.31M
Perspective Therapeutics, Inc. 31.53M
Protalix Biotherapeutics, Inc. 11.16M
Electromed, Inc. 40.21M
Armata Pharmaceuticals, Inc. 12.31M